Mark L Day, PhD

 Mark Day
Professor of Urology, Medical School
Available to mentor
Mark L Day, PhD
Mark Day
Professor
  • Recent Publications

  • Manage Your Profile

    • Recent Publications

     See All Publications
    • Preprint
      TRIM29 is Critical for Bladder Cancer Progression and Modulates the Tumor-Immune Niche.
      Palmbos P, Kelleher A, Henderson M, Broses L, Wang Y, Jerome N, Patsalis C, Bankhead A, Day K, Udager A, Lei YL, Foster B, Huss W, Day M. 2026 May 20; DOI:10.21203/rs.3.rs-9214925/v1
      PMID: 42239777
    • Journal Article
      TRIM29 promotes bladder cancer invasion by regulating the intermediate filament network and focal adhesion
      Wang Y, Jerome NA, Kelleher AJ, Henderson ML, Day ML, Coulombe PA, Palmbos PL. Oncogene, 2025 Nov 4; 44 (42): 4047 - 4057. DOI:10.1038/s41388-025-03557-z
      PMID: 40908312
    • Journal Article
      The Molecular Mechanism of Ambrosin Induced Toxicity of Breast Cancer and Bladder Cancer Cells
      El-Sawy L, John R, Broses L, Pastalis C, Henderson M, Wilson S, Glase S, Munson K, Hiles G, Cates A, Emamdjomeh A, Chu A, Farber J, Kamph J, Magnuson B, Liebert M, Paulson M, Van Golen K, Ljungman M, Bankhead III A, Palmbos P, Day K, Day M. 2025 Apr 2;
    • Journal Article
      Characterization of circulating tumor cells in patients with metastatic bladder cancer utilizing functionalized microfluidics.
      Niu Z, Kozminsky M, Day KC, Broses LJ, Henderson ML, Patsalis C, Tagett R, Qin Z, Blumberg S, Reichert ZR, Merajver SD, Udager AM, Palmbos PL, Nagrath S, Day ML. Neoplasia, 2025 May 10; 57: 101036 - 101036. DOI:10.1016/j.neo.2024.101036
    • Journal Article
      Abstract A003: Characterization of circulating tumor cells from patients with metastatic bladder cancer
      Niu Z, Kozminski M, Day KC, Broses L, Henderson ML, Merajver S, Udager A, Palmbos PL, Nagrath S, Day ML. Clinical Cancer Research, 2024 May 19; 30 (10_Supplement): a003 - a003. DOI:10.1158/1557-3265.bladder24-a003
    • Journal Article
      Abstract A019: TRIM29 enhances the invasion of bladder cancer cells by modulating the intermediate filament network and focal adhesions
      Wang Y, Jerome NA, Kelleher A, Henderson ML, Day M, Coulombe PA, Palmbos PL. Clinical Cancer Research, 2024 May 19; 30 (10_Supplement): a019 - a019. DOI:10.1158/1557-3265.bladder24-a019
    • Journal Article
      Abstract B020: Development of novel Src-targeting strategies to block bladder cancer invasive progression
      Jerome NA, Wang Y, Henderson ML, Broses L, Day KC, Day ML, Soellner MB, Palmbos PL. Clinical Cancer Research, 2024 May 19; 30 (10_Supplement): b020 - b020. DOI:10.1158/1557-3265.bladder24-b020
    • Journal Article
      Abstract PR001: TRIM29 is required for basal bladder cancer invasive progression
      Kelleher A, Broses L, Wang Y, Henderson M, Day M, Udager A, Palmbos P. Clinical Cancer Research, 2024 May 19; 30 (10_Supplement): pr001 - pr001. DOI:10.1158/1557-3265.bladder24-pr001